Fully integrated FET-type gas sensor with optimized signal-to-noise ratio for H2S gas detection

In December 2019, a novel disease, coronavirus disease 19 (COVID-19), emerged in Wuhan, People’s Republic of China. COVID-19 is caused by a novel coronavirus (SARS-CoV-2) presumed to have jumped species from another mammal to humans. This virus has caused a rapidly spreading global pandemic. To date, over 300,000 cases of COVID-19 have been reported in England and over 40,000 patients have died. While progress has been achieved in managing this disease, the factors in addition to age that affect the severity and mortality of COVID-19 have not been clearly identified. Recent studies of COVID-19 in several countries identified links between air pollution and death rates. Here, we explored potential links between major fossil fuel-related air pollutants and SARS-CoV-2 mortality in England. We compared current SARS-CoV-2 cases and deaths from public databases to both regional and subregional air pollution data monitored at multiple sites across England. After controlling for population density, age and median income, we show positive relationships between air pollutant concentrations, particularly nitrogen oxides, and COVID-19 mortality and infectivity. Using detailed UK Biobank data, we further show that PM2.5 was a major contributor to COVID-19 cases in England, as an increase of 1 m3 in the long-term average of PM2.5 was associated with a 12% increase in COVID-19 cases. The relationship between air pollution and COVID-19 withstands variations in the temporal scale of assessments (single-year vs 5-year average) and remains significant after adjusting for socioeconomic, demographic and health-related variables. We conclude that a small increase in air pollution leads to a large increase in the COVID-19 infectivity and mortality rate in England. This study provides a framework to guide both health and emissions policies in countries affected by this pandemic.

Indoor air pollution has traditionally received less attention than outdoors pollution despite indoors pollutant levels are typically twice higher, and people spend 80-90% of their life in increasing air-tight buildings. More than 5 million people die every year prematurely from illnesses attributable to poor indoor air quality, which also causes multi-millionaire losses due to reduced employee's productivity, material damages and increased health system expenses. Indoor air pollutants include particulate matter, biological pollutants and over 400 different chemical organic and inorganic compounds, whose concentrations are governed by several outdoor and indoor factors. Prevention of pollutant is not always technically feasible, so the implementation of cost-effective active abatement units is required. Up to date no single physical-chemical technology is capable of coping with all indoor air pollutants in a cost-effective manner. This problem requires the use of sequential technology configurations at the expenses of superior capital and operating costs. In addition, the performance of conventional physical-chemical technologies is still limited by the low concentrations, the diversity and the variability of pollutants in indoor environments. In this context, biotechnologies have emerged as a cost-effective and sustainable platform capable of coping with these limitations based on the biocatalytic action of plants, bacteria, fungi and microalgae. Indeed, biological-based purification systems can improve the energy efficiency of buildings, while providing additional aesthetic and psychological benefits. This review critically assessed the state-of-the-art of the indoor air pollution problem and prevention strategies, along with the recent advances in physical-chemical and biological technologies for indoor pollutants abatement.